SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Black DM, Delmas P, Eastell R, Reid IR, Boonen S, Cauley J, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Jensen TR, Krasnow J, Hue T, Sellmeyer DE, Eriksen EF, Cummings SR 2007 Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356: 18091817.
  • 2
    Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S 2007 Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357: 17991809.
  • 3
    Amanat N, McDonald M, Godfrey C, Bilston L, Little D 2007 Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. J Bone Miner Res 22: 867876.
  • 4
    Genant HK, Nevitt MC, Black DM, Palemo L, Jergas M, Cummings SR 1993 Assessment of prevalent vertebral fractures combining visual, semiquantitative and morphometric analyses. J Bone Miner Res 8: S338.
  • 5
    O'Brien P, Fleming T 1997 A multiple testing procedure for clinical trials. Biometrics 35: 556.
  • 6
    Voggenreiter G, Klaes W, Assenmacher S, Schmitneuerburg KP 1995 Massive intercalary bone allografts in the treatment of primary and secondary bone-tumors: A report on 21 cases. Arch Orthop Trauma Surg 114: 308318.
  • 7
    Moran CG, Wenn RT, Sikand M, Taylor AM 2005 Early mortality after hip fracture: Is delay before surgery important ? J Bone Joint Surg Am 87: 483489.
  • 8
    Robbins JA, Biggs ML, Cauley J 2006 Adjusted mortality after hip fracture: From the Cardiovascular Health Study. J Am Geriatr Soc 54: 18851891.
  • 9
    Davidson CW, Merrilees MJ, Wilkinson TJ, McKie JS, Gilchrist NL 2001 Hip fracture mortality and morbidity—can we do better ? N Z Med J 114: 329332.
  • 10
    Boonen S, Autier P, Barette M, Vanderschueren D, Lips P, Haentjens P 2004 Functional outcome and quality of life following hip fracture in elderly women: A prospective controlled study. Osteoporos Int 15: 8794.
  • 11
    Ray NF, Chan JK, Thamer M, Melton LJ 1997 Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res 12: 2435.
  • 12
    Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D 2000 Risk of mortality following clinical fractures. Osteoporos Int 11: 556561.
  • 13
    Black DM, Boonen S, Cauley J, Delmas P, Eastell R, Reid I, Rosario-Jansen T, Caminis J, Zhang J, Hu H, Cummings S 2006 Effect of once-yearly infusion of zoledronic acid 5 mg on spine and hip fracture reduction in postmenopausal women with osteoporosis: The HORIZON Pivotal Fracture Trial. J Bone Miner Res 21: S16.